Cytokines, chemokines and growth factors involved in keloids pathogenesis
- PMID: 39799030
- PMCID: PMC11963030
- DOI: 10.1016/j.abd.2024.01.010
Cytokines, chemokines and growth factors involved in keloids pathogenesis
Abstract
Keloid is a common fibrotic disease, which is difficult to treat. It often causes itching and pain, which greatly disturbs patients in their work and daily life and causing difficulties in social interaction. Its pathogenesis is not clear, but may be related to several aspects: genetic susceptibility, environmental, immunological and endocrine factors, trauma and tension. The central point of its pathogenesis is the excessive proliferation of fibroblasts, with excessive synthesis and secretion of extracellular matrix such as collagen. However, the cause of fibroblast excessive proliferation and differentiation is not clear. Immune abnormalities may play an important role, with cytokines, chemokines, growth factors, and other important immune molecules acting on fibroblasts. This paper presents a detailed and comprehensive literature review on this subject.
Keywords: Chemokines; Cytokines; Growth factors; Keloid.
Copyright © 2024 Sociedade Brasileira de Dermatologia. Published by Elsevier España, S.L.U. All rights reserved.
Conflict of interest statement
Conflicts of interest None declared.
Figures


Similar articles
-
Molecular dissection of abnormal wound healing processes resulting in keloid disease.Wound Repair Regen. 2010 Mar-Apr;18(2):139-53. doi: 10.1111/j.1524-475X.2009.00553.x. Epub 2009 Dec 11. Wound Repair Regen. 2010. PMID: 20002895 Review.
-
The Communication from Immune Cells to the Fibroblasts in Keloids: Implications for Immunotherapy.Int J Mol Sci. 2023 Oct 23;24(20):15475. doi: 10.3390/ijms242015475. Int J Mol Sci. 2023. PMID: 37895153 Free PMC article. Review.
-
Asporin inhibits collagen matrix-mediated intercellular mechanocommunications between fibroblasts during keloid progression.FASEB J. 2021 Jul;35(7):e21705. doi: 10.1096/fj.202100111R. FASEB J. 2021. PMID: 34105826
-
Identification of novel immune-related signatures for keloid diagnosis and treatment: insights from integrated bulk RNA-seq and scRNA-seq analysis.Hum Genomics. 2024 Jul 16;18(1):80. doi: 10.1186/s40246-024-00647-z. Hum Genomics. 2024. PMID: 39014455 Free PMC article.
-
Evaluation of genistein ability to modulate CTGF mRNA/protein expression, genes expression of TGFβ isoforms and expression of selected genes regulating cell cycle in keloid fibroblasts in vitro.Acta Pol Pharm. 2014 Nov-Dec;71(6):972-86. Acta Pol Pharm. 2014. PMID: 25745770
Cited by
-
Investigating the Efficacy of Layered Moderate Tension Reduction Suturing in Facial Aesthetic Surgery.Cureus. 2025 May 28;17(5):e85000. doi: 10.7759/cureus.85000. eCollection 2025 May. Cureus. 2025. PMID: 40443833 Free PMC article.
References
-
- Apte R.N., Voronov E. Is interleukin-1 a good or bad’ guy’ in tumor immunobiology and immunotherapy? Immunol Rev. 2008;222:222–241. - PubMed
-
- Guy G.R., Chua S.P., Wong N.S., Ng S.B., Tan Y.H. Interleukin 1 and tumor necrosis factor activate common multiple protein kinases in human fibroblasts. J Biol Chem. 1991;266:14343–14352. - PubMed
-
- Kida Y., Kobayashi M., Suzuki T., Takeshita A., Okamatsu Y., Hanazawa S., et al. Interleukin-1 stimulates cytokines, prostaglandin E2 and matrix metalloproteinase-1 production via activation of MAPK/AP-1 and NF-kappaB in human gingival fibroblasts. Cytokine. 2005;29:159–168. - PubMed
-
- Cilli F., Khan M., Fu F., Wang J.H. Prostaglandin E2 affects proliferation and collagen synthesis by human patellar tendon fibroblasts. Clin J Sport Med. 2004;14:232–236. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources